AMD and Retinal Disease Perspective
- Treatment of Exudative (Wet) Age-Related Macular Degeneration (AMD): The Knowns and the Unknowns
- Tracking the Evolution of Management Options in Wet AMD
- How Home Diagnostic Tools Will Alter the Future of Wet Age-Related Macular Degeneration
- ARVO 2022
- Treatment of Exudative (Wet) Age-Related Macular Degeneration (AMD): The Promise of Meeting the Needs
- Long-Term Anti-VEGF Delivery System Draws Closer to Primetime
- A Look Back at the Evolution in the Management of Exudative (Wet) Age-Related Macular Degeneration
- Machine Learning in Rheumatology: Beyond Clinical Instincts
- Reevaluating the Safety of Brolucizumab for Treating Wet AMD
- Advances in Macular Degeneration From AAO 2021
- AAO 2021
- A Review of Central Retinal Artery Occlusion
- ASRS 2021
- EURETINA 2021
- Google's Head of AI Talks About the Future of the EHR
- ADA 2021
- Vitamin Supplements: Any Role for Heart Disease or Cancer?
- ARVO 2021
- A 53-Year-Old Man With Peripheral Neuropathy
- Increased Screen Time During COVID-19 May Accelerate Myopia Boom